Estimation of plasma irbesartan using HPTLC and HPLC

Indian Drugs

Volumn 40, Issue 2, 2003, Pages 104-110

  Sane, R T ^a   Francis, M ^a   Pawar, S ^a  

^a Therapeutic Drug Monitoring Laboratory   (India)

Author keywords

HPLC; HPTLC; Irbesartan; Losartan; Plasma

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONITRILE; ACETYLSALICYLIC ACID; DRUG METABOLITE; FORMIC ACID; HEPTANE; IBUPROFEN; IRBESARTAN; LOSARTAN; PARACETAMOL; PHOSPHORIC ACID; TOLUENE;

ARTICLE; BIOEQUIVALENCE; CHROMATOGRAPHY; CONTROLLED STUDY; DENSITOMETRY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG STABILITY; ELUTION; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; NORMAL HUMAN; PARTITION COEFFICIENT; QUANTITATIVE ANALYSIS; RESIDUE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; VOLUNTEER;

EID: 0345330933     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Marino M.R., Vachharajani N.N., Hadjilambris O.W.; J Clin Pharmacol (2000) 40(8), 875-9.
2. Vachharajani N.N., Shyu W.C., Chando T.J., Everett D.W., Greene D.S., Barbhaiya R.H.; J Clin Pharmacol, (1998); 38(8), 702-7.
3. Chang S.Y., Whigan D.B., Vachharajani N.N., Patel R.; J Chromatogr B Biomed Sci Appl. (1997) 702(1-2), 149-55.
4. Gonzalez L., Alonso R.M., Jimenez R.M.; Chromatographia (2000) 52(11-12), 735-740.